J. Hindler

发表

CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests

R. Humphries, J. Ambler, S. Mitchell, 2018, Journal of Clinical Microbiology.

Clinical applicability of antifungal susceptibility testing on non-Candida albicans species in hospitalized patients.

J. Hindler, A. Wong-Beringera, L. Branković, 2001, Diagnostic microbiology and infectious disease.

New Delhi Metallo-β-Lactamase (NDM-1)-Producing Klebsiella pneumoniae: Case Report and Laboratory Detection Strategies

R. Humphries, J. Hindler, B. Limbago, 2011, Journal of Clinical Microbiology.

Comparative activity of twelve beta-lactam drugs tested against penicillin-resistant Streptococcus pneumoniae from five medical centers: effects of serum protein and capsular material on potency and spectrum as measured by reference tests.

J. Hindler, G. Doern, R. Jones, 1996, Diagnostic microbiology and infectious disease.

Effect of the source of Mueller-Hinton agar and resistance frequency on the detection of methicillin-resistant Staphylococcus aureus

J. Hindler, C. Inderlied, 1985, Journal of clinical microbiology.

Susceptibility Test Methods: Fastidious Bacteria*

J. Hindler, J. Jorgensen, 2011 .

Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium.

J. Hindler, R. Busuttil, M. Territo, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Vancomycin-intermediate Staphylococcus aureus in a home health-care patient.

S. McAllister, J. Hindler, S. Fridkin, 2001, Emerging infectious diseases.

SME-Type Carbapenem-Hydrolyzing Class A β-Lactamases from Geographically Diverse Serratia marcescens Strains

J. Quinn, J. Hindler, Y. Carmeli, 2000, Antimicrobial Agents and Chemotherapy.

Multicenter Evaluation of the BD Phoenix CPO Detect Test for Detection and Classification of Carbapenemase-Producing Organisms in Clinical Isolates

Charles K. Cooper, J. Hindler, S. Kircher, 2020, Journal of Clinical Microbiology.

Multicenter evaluation of the RAPIDEC® CARBA NP assay for the detection of carbapenemase production in clinical isolates of Enterobacterales and Pseudomonas aeruginosa

Meghan A. Wallace, S. Richter, R. Humphries, 2020, European Journal of Clinical Microbiology & Infectious Diseases.

Evaluation of Ciprofloxacin and Levofloxacin Disk Diffusion and Etest Using the 2019 Enterobacteriaceae CLSI Breakpoints

R. Humphries, J. Hindler, S. Campeau, 2018, Journal of Clinical Microbiology.

Multicenter Evaluation of the Etest Gradient Diffusion Method for Ceftolozane-Tazobactam Susceptibility Testing of Enterobacteriaceae and Pseudomonas aeruginosa

A. Bailey, R. Humphries, J. Hindler, 2018, Journal of Clinical Microbiology.

Performance of Ceftolozane-Tazobactam Etest, MIC Test Strips, and Disk Diffusion Compared to Reference Broth Microdilution for β-Lactam-Resistant Pseudomonas aeruginosa Isolates

R. Humphries, J. Hindler, Shelley A. Miller, 2017, Journal of Clinical Microbiology.

Use of Ancillary Carbapenemase Tests To Improve Specificity of Phenotypic Definitions for Carbapenemase-Producing Enterobacteriaceae

R. Humphries, J. Hindler, Shelley A. Miller, 2017, Journal of Clinical Microbiology.

Evaluation of Oxacillin and Cefoxitin Disk Diffusion and MIC Breakpoints Established by the Clinical and Laboratory Standards Institute for Detection of mecA-Mediated Oxacillin Resistance in Staphylococcus schleiferi

R. Humphries, J. Hindler, L. Westblade, 2017, Journal of Clinical Microbiology.

Multisite Evaluation of Cepheid Xpert Carba-R Assay for Detection of Carbapenemase-Producing Organisms in Rectal Swabs

R. Humphries, J. Hindler, R. Cantón, 2016, Journal of Clinical Microbiology.

Ciprofloxacin-Resistant Haemophilus Influenzae Infection in a Patient with Chronic Lung Disease

J. Hindler, S. Barriere, 1993, The Annals of pharmacotherapy.

The emerging problem of linezolid-resistant Staphylococcus.

R. Humphries, J. Hindler, T. Kelesidis, 2013, The Journal of antimicrobial chemotherapy.

Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae

J. Hindler, P. Murray, M. Ferraro, 1994, Journal of clinical microbiology.

Aminoglycosides in the treatment of bacteraemic infections in the immuno-comprised host.

W. J. Martin, J. Hindler, L. Young, 1981, The Journal of antimicrobial chemotherapy.

Pneumococcal meningitis during therapy of otitis media with clarithromycin.

J. Hindler, J. Bradley, R. Reid, 1995, The Pediatric infectious disease journal.

Performance of Etest and Disk Diffusion for Detection of Ciprofloxacin and Levofloxacin Resistance in Salmonella enterica

R. Humphries, J. Hindler, R. Skov, 2014, Journal of Clinical Microbiology.

In vitro susceptibility testing of fluoroquinolone activity against Salmonella: recent changes to CLSI standards.

F. Aarestrup, R. Humphries, J. Hindler, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Performance of Vitek 2 for Antimicrobial Susceptibility Testing of Staphylococcus spp. and Enterococcus spp

R. Humphries, J. Hindler, A. Bobenchik, 2013, Journal of Clinical Microbiology.

Should laboratories test methicillin-resistant Staphylococcus aureus for elevated vancomycin minimum inhibitory concentrations by Etest as a driver of treatment changes?

R. Humphries, J. Hindler, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Frequency of Susceptibility Testing for Patients with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia

R. Humphries, J. Hindler, T. Kelesidis, 2013, Journal of Clinical Microbiology.

Performance of Etest for Antimicrobial Susceptibility Testing of Abiotrophia defectiva and Granulicatella Species

R. Humphries, J. Hindler, M. O. Alberti, 2016, Journal of Clinical Microbiology.

Antimicrobial Susceptibilities of Abiotrophia defectiva, Granulicatella adiacens, and Granulicatella elegans

R. Humphries, J. Hindler, M. O. Alberti, 2015, Antimicrobial Agents and Chemotherapy.

Antimicrobial susceptibility testing of gram-negative bacteria: meeting the challenge of increasing resistance and decreasing budgets

J. Hindler, 1995 .

Impact of prolonged incubation on disk diffusion susceptibility test results for Staphylococcus aureus

J. Hindler, D. Citron, M. Mulligan, 1987, Journal of clinical microbiology.

Effect oftheSource ofMueller-Hinton AgarandResistance Frequency on theDetection ofMethicillin-Resi

J. Hindler, Clark B. INDERLIEDt, 1985 .

Rapid identification of Mycobacterium avium complex in culture using DNA probes

T. Drake, J. Hindler, D. Bruckner, 1987, Journal of clinical microbiology.

What’s New in Antibiograms? Updating CLSI M39 Guidance with Current Trends

J. Hindler, Sanchita Das, J. K. Johnson, 2022, Journal of clinical microbiology.

Molecular characterization and multilaboratory evaluation of Enterococcus faecalis ATCC 51299 for quality control of screening tests for vancomycin and high-level aminoglycoside resistance in enterococci

M. Weinstein, J. Hindler, M. Ferraro, 1995, Journal of clinical microbiology.

Aminoglycoside resistance: a worldwide perspective.

J. Hindler, L. Young, 1986, The American journal of medicine.

Overview of Changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st Edition

R. Humphries, J. Hindler, A. Schuetz, 2021, Journal of clinical microbiology.

In Vitro Activity of Daptomycin in Combination with β-Lactams, Gentamicin, Rifampin, and Tigecycline against Daptomycin-Nonsusceptible Enterococci

V. Nizet, R. Humphries, J. Hindler, 2015, Antimicrobial Agents and Chemotherapy.

Evolution and Transmission of Carbapenem-Resistant Klebsiella pneumoniae Expressing the bla OXA-232 Gene During an Institutional Outbreak Associated With Endoscopic Retrograde Cholangiopancreatography

A. Kasarskis, R. Sebra, R. Humphries, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Fluoroquinolone Resistance in Salmonella and the Utility of Perﬂoxacin Disk Diffusion

R. Humphries, J. Hindler, G. Kahlmeter, 2015 .

Colistin MIC Variability by Method for Contemporary Clinical Isolates of Multidrug-Resistant Gram-Negative Bacilli

R. Humphries, J. Hindler, 2013, Journal of Clinical Microbiology.

Antibiotics in Laboratory Medicine Edited by Victor Lorian. 4th ed. Baltimore: Williams & Wilkins, 1996. 1,238 pp., illustrated. $189

E. Baron, J. Hindler, 1997 .

Interpretive guidelines for antimicrobial susceptibility test results: What do they mean?

J. Hindler, L. Thrupp, 1989 .

Clinical and Microbiological Aspects of β-Lactam Resistance in Staphylococcus lugdunensis

R. Humphries, J. Hindler, K. Bruxvoort, 2016, Journal of Clinical Microbiology.

Evaluation of the AutoMicrobic system for susceptibility testing of aminoglycosides and gram-negative bacilli

J. Hindler, D. Bruckner, 1987, Journal of clinical microbiology.

Rationale for eliminating Staphylococcus breakpoints for β-lactam agents other than penicillin, oxacillin or cefoxitin, and ceftaroline.

J. Hindler, B. Limbago, J. Dien Bard, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli

W. J. Martin, J. Hindler, L. Young, 1980, Antimicrobial Agents and Chemotherapy.

Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections.

Anne Yusof, Annie Wong-Beringer, J. Hindler, 2008, International journal of antimicrobial agents.

Aerococcus urinae and Trimethoprim-Sulfamethoxazole

R. Humphries, J. Hindler, Courtney Lee, 2011, Journal of Clinical Microbiology.

Emerging Resistance, New Antimicrobial Agents … but No Tests! The Challenge of Antimicrobial Susceptibility Testing in the Current US Regulatory Landscape.

R. Humphries, J. Hindler, R M Humphries, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Bioactivity of imipenem as a function of medium, time, and temperature

E. Baron, J. Hindler, 1984, Antimicrobial Agents and Chemotherapy.

In Vitro Antimicrobial Susceptibility of Aerococcus urinae

R. Humphries, J. Hindler, 2014, Journal of Clinical Microbiology.

Investigation of a suspected nosocomial transmission of blaKPC3-mediated carbapenem-resistant Klebsiella pneumoniae by whole genome sequencing.

R. Humphries, J. Hindler, P. Hemarajata, 2016, Diagnostic microbiology and infectious disease.

Reliability of two novel methods, Alamar and E test, for detection of methicillin-resistant Staphylococcus aureus

J. Hindler, D. Bruckner, S. Novak, 1993, Journal of clinical microbiology.

Precision of Vancomycin and Daptomycin MICs for Methicillin-Resistant Staphylococcus aureus and Effect of Subculture and Storage

R. Humphries, J. Hindler, J. Turnidge, 2014, Journal of Clinical Microbiology.

First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate

R. Humphries, J. Hindler, P. Hemarajata, 2015, Antimicrobial Agents and Chemotherapy.

Evaluation of Oxacillin and Cefoxitin Disk and MIC Breakpoints for Prediction of Methicillin Resistance in Human and Veterinary Isolates of Staphylococcus intermedius Group

Meghan A. Wallace, R. Humphries, J. Hindler, 2015, Journal of Clinical Microbiology.

Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium. National Committee for Clinical Laboratory Standards.

J. Hindler, G. Doern, R. Jones, 1994, Diagnostic microbiology and infectious disease.

In vitro activity of A-56268 (TE-031), a new macrolide antibiotic, compared with that of erythromycin and other antimicrobial agents

J. Hindler, L. Young, S. Floyd-Reising, 1987, Antimicrobial Agents and Chemotherapy.

Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime.

Annie Wong-Beringer, J. Quinn, J. Hindler, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Activity of Ceftolozane-Tazobactam and Ceftazidime-Avibactam against Beta-Lactam-Resistant Pseudomonas aeruginosa Isolates

R. Humphries, J. Hindler, Shelley A. Miller, 2017, Antimicrobial Agents and Chemotherapy.

Understanding and Addressing CLSI Breakpoint Revisions: a Primer for Clinical Laboratories

R. Humphries, J. Hindler, A. Abbott, 2019, Journal of Clinical Microbiology.

Parenteral infusions as culture media from a viewpoint of nosocomial bacteremia.

J. Hindler, D. Bruckner, A. Macías, 2000, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

Digital Quantification of DNA Replication and Chromosome Segregation Enables Determination of Antimicrobial Susceptibility after only 15 Minutes of Antibiotic Exposure.

R. Ismagilov, R. Humphries, J. Hindler, 2016, Angewandte Chemie.

In Vitro Antimicrobial Susceptibility of Staphylococcus pseudintermedius Isolates of Human and Animal Origin

R. Humphries, J. Hindler, C. Burnham, 2016, Journal of Clinical Microbiology.

Multicenter Evaluation of a Modified Cefoxitin Disk Diffusion Method and PBP2a Testing To Predict mecA-Mediated Oxacillin Resistance in Atypical Staphylococcus aureus

S. Richter, Robin Patel, R. Humphries, 2016, Journal of Clinical Microbiology.

Stability of viable-bacterium counts in liquid media used for preparation of inocula and subsequent impact on antimicrobial susceptibility test results

T. Drake, J. Hindler, A. H. González, 1990, Journal of Clinical Microbiology.

Performance of Vitek 2 for Antimicrobial Susceptibility Testing of Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia with Vitek 2 (2009 FDA) and CLSI M100S 26th Edition Breakpoints

R. Humphries, J. Hindler, A. Bobenchik, 2016, Journal of Clinical Microbiology.

Twenty-first Century Cures Act and Antimicrobial Susceptibility Testing: Clinical Implications in the Era of Multidrug Resistance

R. Humphries, J. Hindler, A. Mathers, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Mechanisms of Linezolid Resistance among Coagulase-Negative Staphylococci Determined by Whole-Genome Sequencing

N. Schork, R. Tewhey, R. Humphries, 2014, mBio.

Cefuroxime screening test for pneumococci

J. Hindler, M. Ferraro, F. Tenover, 1993, Journal of clinical microbiology.

Performance of Vitek 2 for Antimicrobial Susceptibility Testing of Enterobacteriaceae with Vitek 2 (2009 FDA) and 2014 CLSI Breakpoints

R. Humphries, J. Hindler, A. Bobenchik, 2014, Journal of Clinical Microbiology.

Multicenter Performance Assessment of Carba NP Test

Robin Patel, J. Mandrekar, R. Humphries, 2017, Journal of Clinical Microbiology.

Phenotypic and Molecular Characteristics of Carbapenem-Resistant Enterobacteriaceae in a Health Care System in Los Angeles, California, from 2011 to 2013

R. Humphries, J. Hindler, S. Miller, 2014, Journal of Clinical Microbiology.

Contemporary Considerations for Establishing Reference Methods for Antibacterial Susceptibility Testing

B. Zimmer, R. Humphries, J. Hindler, 2023, Journal of clinical microbiology.

Carbapenem-Resistant Enterobacteriaceae Detection Practices in California: What Are We Missing?

R. Humphries, J. Hindler, Sam Horwich-Scholefield, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of 21st Century Cures Act on Breakpoints and Commercial Antimicrobial Susceptibility Test Systems: Progress and Pitfalls

R. Humphries, J. Hindler, M. Ferraro, 2018, Journal of Clinical Microbiology.

Two-Site Evaluation of the Colistin Broth Disk Elution Test To Determine Colistin In Vitro Activity against Gram-Negative Bacilli

R. Humphries, J. Hindler, P. Tamma, 2018, Journal of Clinical Microbiology.

Development of a Novel Real-Time PCR Assay with High-Resolution Melt Analysis To Detect and Differentiate OXA-48-Like β-Lactamases in Carbapenem-Resistant Enterobacteriaceae

R. Humphries, J. Hindler, P. Hemarajata, 2015, Antimicrobial Agents and Chemotherapy.

Biclonal Bacteremia due to Stenotrophomonas maltophilia in a Cancer Patient

J. Hindler, A. Lechner, S. Nelson, 2001, European Journal of Clinical Microbiology and Infectious Diseases.

DNA probe reactivity of Mycobacterium avium complex isolates from patients without AIDS.

T. Drake, J. Hindler, D. Bruckner, 1988, Diagnostic microbiology and infectious disease.

Bioactivity ofImipenem as a Function ofMedium,Time,and Temperature

J. Hindler, Ellen J. BARONt, 1984 .

Serum bactericidal activity from intravenous ciprofloxacin and azlocillin given alone and in combination to healthy subjects.

J. Hindler, S. Barriere, P. Orlando, 1990, Diagnostic microbiology and infectious disease.

Phenotypic and Molecular Characteristics of Carbapenem-Resistant Enterobacteriaceae in a Health Care System in Los Angeles, California, from 2011 to 2013

R. Humphries, J. Hindler, D. Uslan, 2014, Journal of Clinical Microbiology.

Photo Quiz: A 46-Year-Old Man with a Lung Mass and History of Hemoptysis

Robin Patel, R. Humphries, J. Hindler, 2017, Journal of Clinical Microbiology.

Public Health Efforts Can Impact Adoption of Current Susceptibility Breakpoints, but Closer Attention from Regulatory Bodies Is Needed

R. Humphries, J. Hindler, B. Schwartz, 2018, Journal of Clinical Microbiology.

Antimicrobial Susceptibilities of Abiotrophia defectiva, Granulicatella adiacens, and Granulicatella elegans

R. Humphries, J. Hindler, M. O. Alberti, 2015, Antimicrobial Agents and Chemotherapy.

First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate

R. Humphries, J. Hindler, P. Hemarajata, 2015, Antimicrobial Agents and Chemotherapy.

Revised disk diffusion interpretive criteria for cefaclor, loracarbef, cefprozil and cefixime when testingHaemophilus influenzae on Haemophilus Test Medium

J. Hindler, G. Doern, R. Jones, 1994, European Journal of Clinical Microbiology and Infectious Diseases.

R. Humphries, J. Hindler, L. Westblade, 2017, Journal of Clinical Microbiology.

Clinical and Laboratory Standards Institute (CLSI) Evaluation of Oxacillin and Cefoxitin Disk Diffusion and Minimum Inhibitory Concentration Breakpoints for Detection of mecA-mediated Oxacillin Resistance in Staphylococcus schleiferi

Bemis, R. Humphries, J. Hindler, 2017 .